In the News: EU Foreign Investment Screening and Pharma Legislation Overhauls; and Hong Kong IPO Applications

The EU has reached a provisional deal requiring member states to screen foreign investments and changed its pharmaceutical legislation after over 20 years; and Hong Kong has warned investment banks not to prepare substandard IPO applications.

Promulgated: 2025-12-11

Plenary room in EU parliament. Assembly room of European Parliament. Institutions of European Union in Bruxelles. Credit: Ajdin Kamber/Adobe StockPlenary room in EU parliament. Assembly room of European Parliament. Institutions of European Union in Bruxelles. Credit: Ajdin Kamber/Adobe Stock

EU Presses Ahead with Foreign Investment Screening Measures

Two key bodies of the European Union (EU) have reached a provisional deal to require the screening of foreign investments in sensitive sectors, Reuters reports.

This premium content is reserved for <br> China Law & Practice Subscribers. subscribers only

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]